ResMed
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.About RMD
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases.
RMD Key Statistics
RMD News
ResMed Inc showcases robust revenue growth in its latest quarterly report. Investments in R&D and digital health initiatives position the company for future gr...
In this article: ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales...
Shares of ResMed (NYSE: RMD) had soared 16.2% higher as of 11:50 a.m. ET on Friday. The big jump came after the healthcare technology company reported results o...
Analyst ratings
71%
of 24 ratingsMore RMD News
ResMed (RMD) stock jumped to an eight-month high Friday after crushing first-quarter estimates and wiping out worries that weight-loss drugs would squeeze its s...
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has OrganiGram (OGI) been one of those stock...
Oppenheimer lowered the firm’s price target on ResMed to $200 from $205 and keeps an Outperform rating on the shares. ResMed’s Q3 earnings were in line with est...
Loading... Loading... ResMed RMD reported better-than-expected third-quarter financial results on Thursday. ResMed posted adjusted earnings of $2.13 per share...
Needham raised the firm’s price target on ResMed to $236 from $224 and keeps a Buy rating on the shares. The company’s Q3 earnings and revenue topped estimates,...
ResMed Inc.’s RMD adjusted earnings per share (EPS) for the third quarter of fiscal 2024 were $2.13, up 26.8% year over year. The metric beat the Zacks Consensu...
STOCKSTOWATCHTODAY BLOG Shares of ResMed were trading sharply higher after the medical devices company filed a quarterly report that left Wall Street cheering....
